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Rickettsia 
aeschlimannii 
Infection, Algeria
To the Editor: Only 2 cases of 
Rickettsia aeschlimannii infection 
have been reported. We report 2 addi-
tional cases documented in Algeria by 
immunoﬂ  uorescence (IF) assays and 
conﬁ  rmed by Western blot (WB) as-
says and cross-adsorption studies. 
Tick-borne rickettsioses are now 
recognized as emerging or reemerging 
human infections worldwide. These 
zoonoses, caused by intracellular bac-
teria within spotted fever group (SFG) 
Rickettsia spp., share characteristic 
clinical features including fever, rash, 
and sometimes inoculation eschar at 
the bite site (1). In North Africa, cases 
of rickettsioses are rarely documented 
(2). In Algeria, only Mediterranean 
spotted fever caused by R. conorii has 
been described (3).
From 2000 through 2006 in Al-
geria, all patients with suspected rick-
ettsioses seen at the infectious diseases 
units of Constantine and Batna hos-
pitals were included in a prospective 
study; clinical and epidemiologic data 
and acute-and convalescent-phase se-
rum samples obtained 2–4 weeks later 
were collected. Serum samples were 
sent to Marseille, France, where they 
were analyzed by an IF assay, using 
9 SFG rickettsial antigens (R. conorii 
conorii, R. conorii israelensis, R. afri-
cae, R. sibirica mongolitimonae, R. ae-
schlimannii, R. massiliae, R. helvetica, 
R. slovaca, and R. felis) and a typhus 
group antigen (R. typhi) (3). The IF as-
say result was considered positive 1) 
if immunoglobulin (Ig) G titers were 
>128 and/or IgM titers were >64 for R. 
conorii and 2) if IgG titers were >64 
and/or IgM titers were >32 for other 
rickettsial antigens (3). When cross-re-
actions between several antigens were 
noted, rickettsial antigen was consid-
ered to represent the infectious agent 
if titers of IgG and/or IgM antibody 
against this antigen were at least 2-fold 
higher than titers of IgG and/or IgM 
antibody against other rickettsial anti-
gens (3,4). When the difference in ti-
ters among several antigens was lower 
than 2-fold, WB assays and cross-ad-
sorption studies were performed (4,5). 
A total of 135 patients were included in 
the study. We describe 2 cases of R. ae-
schlimannii infection. Cases caused by 
other SFG rickettsiae will be reported 
elsewhere.
An 80-year-old man who report-
ed contact with dogs parasitized by 
ticks had a 7-day history of high fe-
ver, headache, myalgia, and vomiting. 
On physical examination, a general-
ized maculopapular rash, 2 eschars 
(right shoulder and knee), and bilat-
eral hemorrhagic signs on the retina 
were noticed. Elevated levels of liver 
enzymes (aspartate aminotransferase 
187 U/L, alanine aminotransferase 
108 U/L), hyponatremia (sodium 120 
mmol/L), and hypokalemia (potas-
sium 2.9 mmol/L) were found. IF as-
say showed raised levels of IgG/IgM 
against  R. aeschlimannii (512/64) 
and R. conorii (128/0). 
The second patient, a 36-year-
old man, reported a 15-day history 
of fever with headache and failure of 
amoxicillin and cotrimoxazole treat-
ments. Oral aphtous, a maculopapu-
lar rash, and purpuric lesions on the 
arms were noticed. IF assay showed 
raised levels of IgG/IgM at the same 
titer (2,048/32) against R. conorii, R. 
aeschlimannii, and R. massiliae. WB 
assays and cross-adsorption studies 
conﬁ  rmed that antibodies were direct-
ed against R. aeschlimannii (Figure). 
Both patients recovered after doxycy-
cline treatment (1). 
R. aeschlimannii was ﬁ  rst charac-
terized as a new SFG rickettsia after 
its isolation from Hyalomma margin-
atum marginatum ticks in Morocco in 
1997 (6). Thereafter, R. aeschlimannii 
has been detected in this tick species 
in southern Europe and North Africa 
(7), as well as in H. m. ruﬁ  pes in sub-
Saharan Africa (1). Preliminary data 
have suggested that these Hyalomma 
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organisms may be not only vectors 
but also reservoirs of R. aeschlimannii 
and as a consequence, the geographic 
distribution of R. aeschlimannii would 
be at least that of these ticks through-
out southern Europe and Africa (8). 
Although WB assays and cross-
adsorption studies are time-consum-
ing and only available in specialized 
reference laboratories, new data can 
be obtained for a better understanding 
of rickettsioses. We have added the de-
scription of 2 more cases of infection 
with R. aeschlimannii. Only 2 cases of 
human infection caused by this rickett-
sia had been previously reported, in-
cluding infection in a patient returning 
to France from Morocco, and another 
in a patient in South Africa (9,10). 
Clinicians should be aware that 
several tick-borne rickettsial patho-
gens are present in Algeria. Speciﬁ  c 
clinical features may be directly inﬂ  u-
enced by the Rickettsia spp. involved, 
the rickettsial infection rate of the vec-
tor, and tick behavior. H. marginatum 
ticks readily bite humans, and persons 
may receive multiple simultaneous tick 
bites. Furthermore, the high infectious 
rate of these ticks by R. aeschliman-
nii has been reported (1). Therefore, 
the probability of being bitten by sev-
eral infected H. marginatum ticks is 
high and can lead to several eschars in 
patients, a characteristic of few tick-
borne rickettsioses. Finally, although 
doxycycline is the reference treatment 
for rickettsioses, rifampin has been 
used (1). However, although R. conorii 
is susceptible in vitro to this drug, R. 
aeschlimannii is resistant. Because pa-
tients suspected of having rickettsiosis 
must receive prompt presumptive treat-
ment, the presence of R. aeschlimannii 
in Morocco reinforces the need to use 
doxycycline as a ﬁ  rst-line drug. 
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Figure. Western blot assay (WB) and cross-adsorption studies in serum of a patient with 
rickettsiosis in Algeria. Immunoﬂ  uorescent assay showed raised levels of immunoglobulin 
(Ig) G/M at the same titer (2,048/32) against Rickettsia conorii, R. aeschlimannii, and R. 
massiliae. Lanes Rc, Rae, and Rm: WB assay using R. conorii, R. aeschlimannii, and 
R. massiliae antigens, respectively. MW, molecular weights are indicated on the left. 
Untreated serum, late serum samples tested by WB. When adsorption is performed with 
R. aeschlimannii antigens, homologous and heterologous antibodies disappear, but when 
it is performed with R. conorii antigens and R. massiliae, homologous antibodies disappear 
but heterologous antibodies persist. This result indicates that antibodies are speciﬁ  cally 
directed against R. aeschlimannii. Abs, absorbed.
MW      Rc Rae    Rm MW    Rc Rae   Rm MW     Rc Rae  Rm MW     Rc Rae    Rm
135 kd
Untreated serum Abs R. conorii Abs R. aeschlimannii Abs R. massiliae